SUPERNUS PHARMACEUTICALS INC shareholders Q2 2024

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 239 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.

SUPERNUS PHARMACEUTICALS INC shareholders Q2 2024
NameSharesValueWeighting ↓
SUSQUEHANNA INTERNATIONAL GROUP, LLP 7,900$211,3250.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 12,402$331,7540.00%
ROYAL BANK OF CANADA 5,461$145,0000.00%
Parallel Advisors, LLC 12$3210.00%
OSAIC HOLDINGS, INC. 1,087$29,0770.00%
Allworth Financial LP 40$1,2100.00%
Abound Wealth Management 12$3210.00%
SIGNATUREFD, LLC 561$15,0070.00%
RFP Financial Group LLC 27$7220.00%
HOLLENCREST CAPITAL MANAGEMENT 80$2,1400.00%
Versant Capital Management, Inc 16$4280.00%
JPMORGAN CHASE & CO 180,278$4,822,4380.00%
SRS Capital Advisors, Inc. 139$3,7190.00%
LAZARD ASSET MANAGEMENT LLC 2,205$580.00%
Lindbrook Capital, LLC 66$1,7660.00%
Mitsubishi UFJ Asset Management Co., Ltd. 202$5,4040.00%
NISA INVESTMENT ADVISORS, LLC 1,650$44,1380.00%
DEUTSCHE BANK AG\ 25,659$686,3790.00%
Daiwa Securities Group Inc. 157$40.00%
HUNTINGTON NATIONAL BANK 748$20,0090.00%
External links

This page lists SUPERNUS PHARMACEUTICALS INC's shareholders in Q2 2024. To view SUPERNUS PHARMACEUTICALS INC's shareholder history, click here.